Survival rates for patients at high risk of relapse of childhood leukemia improve with high doses of chemotherapy drug
Tuesday, April 26, 2016 - 12:30
in Health & Medicine
Up to 20 percent of patients with high risk of relapse of acute lymphoblastic leukemia (ALL) are not cured. That could change with the results from a clinical trial that shows giving high doses of a commonly-used chemotherapy drug increases survival rates.